Support for developing drugs and vaccines for emerging infections
Core 3: Biocontainment Research Support Services Core
This study is working to improve how we develop new medicines and vaccines for infections by making better testing methods and understanding how our immune system responds, which could lead to better treatments for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10910128 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the Duke Regional Biocontainment Laboratory to support the development of drugs, diagnostics, and vaccines for emerging and re-emerging infections. It aims to refine small animal models for testing and improve virology programs by establishing direct workflows from clinical laboratories. Additionally, the project will broaden immunological assays to monitor immune responses to various pathogens. Patients may benefit indirectly through advancements in treatments and vaccines for infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals affected by emerging infectious diseases, such as COVID-19 or other viral infections.
Not a fit: Patients with non-infectious diseases or those not affected by the targeted viral infections may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for serious infectious diseases.
How similar studies have performed: Previous research has shown success in developing treatments and vaccines for infectious diseases using similar biocontainment and animal model approaches.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Duckett, Colin S. — Duke University
- Study coordinator: Duckett, Colin S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.